Global Bioresorbable Vascular Scaffold Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The Bioresorbable Vascular Scaffold (BVS) is a non-metallic mesh tube that is generally used in the treatment of a narrowed artery. The BVC completely gets absorbed by the body leaving no foreign material. Factors such as the growing geriatric population and increasing incidences of target diseases such as rheumatic heart disease, coronary heart disease, peripheral arterial disease, cerebrovascular disease, congenital heart disease, and pulmonary embolism are driving the global market growth.

According to the World Health Organization (WHO), it was estimated that approximately 17.9 million people worldwide die every year because of cardiovascular diseases. Therefore, the high prevalence of CVDs is propelling the demand for Bioresorbable Vascular Scaffold, which, in turn, augments the market growth across the globe. In addition, rising technological advancements and a robust product pipeline are presenting lucrative opportunities for growth in the market during the forecast period. However, lack of awareness about bioresorbable vascular scaffolds and high costs related to the R&D activities are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bioresorbable Vascular Scaffold Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe dominated the market in terms of revenue, owing to the presence of skilled professionals and growing investment in R&D activities. Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising expenditure on healthcare, as well as growing incidences of target diseases.

Major market players included in this report are:

Meril Life Sciences

Abbott

Cook Medical

Boston Scientific Corporation

W.L. Gore & Associates, Inc.

Medtronic

Stentys SA

MAQUET Holding B.V. & Co. KG (Getinge AB)

B. Braun Melsungen AG

Terumo Corporation

Recent Developments in the Market:

In May 2021, a study of patients with relatively simple coronary artery lesions unveils that some early promise for a new bioresorbable scaffold such as Firesorb, MicroPort Medical.
In January 2019, Reva Medical announced the expansion of the company's commercial operations to seven additional European countries that are Estonia, Poland, Slovakia, Russia, Lithuania, the Czech Republic, and Latvia four new regional distribution partnerships.
Global Bioresorbable Vascular Scaffold Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered Application, End User, Region

Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:

Peripheral Artery

Coronary Artery

By End User:

Hospitals

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World